Search clinical trials for: Mitogen-activated Protein Kinase (MEK) inhibitor
Total 77260 results
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Henan Cancer HospitalRecruitingDigestive System TumorsChina
-
Fondation Ophtalmologique Adolphe de RothschildCompletedMEK Inhibitor-Associated Serous RetinopathyFrance
-
BioMed Valley Discoveries, IncTerminatedAdvanced Solid Tumor | MAP2K1 Gene Mutation | BRAF Gene Mutation | MEK Mutation | BRAF Gene Alteration | MEK Alteration | MAP2K1 Gene Alteration | MAP2K2 Gene Mutation | MAP2K2 Gene AlterationUnited States
-
GlaxoSmithKlineCompleted
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
CStone PharmaceuticalsCompletedSolid Tumor, AdultAustralia
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteUnited States
-
M.D. Anderson Cancer CenterArray BioPharmaTerminated
-
Shanghai Henlius BiotechRecruiting
-
University Health Network, TorontoRecruitingArteriovenous MalformationsCanada
-
SpringWorks Therapeutics, Inc.AvailableNeurofibromatosis Type 1-Associated Plexiform Neurofibromas | Histiocytic Neoplasm | Other MAP-K Pathway Driven Diseases
-
Genentech, Inc.Completed
-
Array Biopharma, now a wholly owned subsidiary...Completed
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminated
-
Array Biopharma, now a wholly owned subsidiary...Completed
-
University of OxfordPfizer; Belfast Health and Social Care Trust; Queen's University, Belfast; Saint... and other collaboratorsCompletedColorectal Cancer | Solid TumorUnited Kingdom
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorJapan
-
Dana-Farber Cancer InstituteNovartisActive, not recruiting
-
Genentech, Inc.Terminated
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of Alabama at BirminghamCompletedNeurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PNUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingGastrointestinal Stromal Tumor (GIST)United States
-
Ikena OncologyRecruitingColorectal Cancer | Pancreatic Cancer | Thyroid Carcinoma | Solid Tumor, Adult | Malignant Melanoma | Non-Small Cell Lung Carcinoma | BRAF Gene Mutation | Gliomas, Malignant | Ras (Kras or Nras) Gene Mutation | CRAF Gene MutationUnited States
-
The Christie NHS Foundation TrustAstraZeneca; Cancer Research UKTerminatedRectal CancerUnited Kingdom
-
Dana-Farber Cancer InstituteEli Lilly and CompanyActive, not recruiting
-
Novartis PharmaceuticalsCompletedCancerFrance, Belgium, Netherlands, United States, Spain, Japan, United Kingdom, Italy
-
National Cancer Institute (NCI)Completed
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Melanoma | Stage IV MelanomaUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedRheumatoid ArthritisBrazil, Argentina, United States, Poland, Hungary, Peru, Romania
-
GlaxoSmithKlineTerminatedMelanoma and Brain MetastasesUnited States, Australia
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Cancer | Metaplasia | Stage I Gastric Cancer | Initial-onset Gastric CancerJapan
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
Merck Sharp & Dohme LLCArray BioPharmaCompletedMetastatic Colorectal CancerUnited States, Canada
-
M.D. Anderson Cancer CenterArray BioPharmaTerminated
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Atriva Therapeutics GmbHSGS Life Sciences, a division of SGS Belgium NVCompleted
-
BayerCompletedPancreatic NeoplasmsUnited Kingdom, Germany, United States, Czechia, Belgium, Norway, Poland, Italy, France
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
Hospices Civils de LyonUnknownMetastatic NRAS MelanomaFrance
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
PfizerTerminatedLow-grade Serous Ovarian Cancer | Low-grade Serous Fallopian Tube Cancer | Low-grade Serous Peritoneal CancerUnited States, Canada, Hungary, Spain, Belgium, France, United Kingdom, Australia, Czechia, Netherlands, Sweden, Italy, Denmark, Germany, Austria, Finland, Ireland, Norway, Poland
-
Array Biopharma, now a wholly owned subsidiary...WithdrawnCardiomegalyUnited States, United Kingdom
-
EuMelaReg gGmbHActive, not recruiting
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
PfizerTerminatedAdvanced CancerItaly, United States, Canada, Spain
-
University of ArizonaCompletedMelanoma | Renal Cell Carcinoma | HCC | Hepatocellular Carcinoma | Metastatic Cancer | Metastatic Melanoma | Colon Cancer | Differentiated Thyroid Cancer | Metastatic Colon CancerUnited States